Interleukin (IL)-16 is a proinflammatory cytokine that has attracted widespread attention because of its ability to block HIV replication. We describe the identification and characterization of a large neuronal IL-16 precursor, NIL-16. The N-terminal half of NIL-16 constitutes a novel PDZ domain protein sequence, whereas the C terminus is identical with splenocyte-derived mouse pro-IL-16. IL-16 has been characterized only in the immune system, and the identification of NIL-16 marks a previously unsuspected connection between the immune and the nervous systems. NIL-16 is a cytosolic protein that is detected only in neurons of the cerebellum and the hippocampus. The N-terminal portion of NIL-16 interacts selectively with a variety of neuronal ion channels, which is similar to the function of many other PDZ domain proteins that serve as intracellular scaffolding proteins. Among the NIL-16-interacting proteins is the class C ␣1 subunit of a mouse brain calcium channel (mbC ␣1). The C terminus of NIL-16 can be processed by caspase-3, resulting in the release of secreted IL-16. Furthermore, in cultured cerebellar granule neurons undergoing apoptosis, NIL-16 proteolysis parallels caspase-3 activation. Cerebellar granule neurons express the IL-16 receptor CD4. Exposure of these cells to IL-16 induces expression of the immediate-early gene, c-fos, via a signaling pathway that involves tyrosine phosphorylation. This suggests that IL-16 provides an autocrine function in the brain. Therefore, we hypothesize that NIL-16 is a dual function protein in the nervous system that serves as a secreted signaling molecule as well as a scaffolding protein.
Interleukin (IL)-16 (also known as lymphocyte chemoattractant factor; Cruikshank et al., 1994 ) is a T-cell-derived cytokine with pleiotropic, pro-inflammatory effects in the immune system (for review, see Cruikshank et al., 1998) . IL -16 has gained considerable attention recently because of its ability to inhibit the replication of the human immunodeficiency virus (HIV) in infected T-cells by interfering with HIV mRNA expression (Baier et al., 1995; Z hou et al., 1997) . IL -16 is a 121-amino-acid peptide secreted by T-lymphocytes. It is derived by proteolytical cleavage of an 80 kDa precursor molecule, pro-IL -16 (Baier et al., 1997) . In vitro, the processing of pro-IL -16 to yield IL -16 is catalyzed by caspase-3 (Z hang et al., 1998) . This cleavage reaction is reminiscent of the processing of pro-IL -1 by caspase-1 (Black et al., 1988; Kostura et al., 1989) .
IL-16 exerts its effects via binding to a cell surface receptor, CD4 (Cruikshank et al., 1994; Center et al., 1996) . CD4 was described originally as a protein expressed primarily in T-cells, where it is involved in antigen recognition in the context of class II major histocompatibility molecules (for review, see Parnes, 1989) . Subsequently, CD4 expression was described in neurons, glia, and microglia throughout the brain (Funke et al., 1987; Perry and Gordon, 1987; Peudenier et al., 1991; Omri et al., 1994) . Pyramidal neurons of the hippocampus as well as granule neurons of the dentate gyrus, the cerebellum, and the olfactory bulb display particularly high levels of CD4 expression (Omri et al., 1994) . However, to date the CD4 ligand IL-16 has been detected only in the immune system (Chupp et al., 1998; Keane et al., 1998) . Here we report the identification and characterization of a neuronal variant of Although the C -terminal region of N IL -16 is identical to splenocyte-derived mouse pro-IL -16 (Keane et al., 1998) , the N-terminal portion of the molecule constitutes a novel protein sequence. N IL -16 is a cytosolic multi-PDZ domain protein that is expressed postnatally and throughout adulthood. Its mRNA is localized to neurons of the cerebellum and the hippocampus. The N terminus of N IL -16 physically interacted with the cytoplasmic domains of a variety of neuronal ion channels. Moreover, N IL -16 could be coimmunoprecipitated with the NMDA receptor subunit 2A (N R2A) from transfected cells. Therefore, we speculate that N IL -16 may be involved in the targeting and clustering of neurotransmitter receptors, which would be similar to the f unction of several other PDZ domain proteins (for review, see Ponting et al., 1997; Sheng and Wyszynski, 1997) . In contrast, the C terminus of N IL -16 could be proteolysed by caspase-3, which resulted in the release of secreted mature IL -16. In cultured cerebellar granule neurons (CGN) induced to undergo apoptosis, N IL -16 proteolysis was associated with caspase-3 activation. Moreover, IL -16 treatment of cultured CGN resulted in the induction of the immediate-early gene, c-fos, indicating that IL -16 is capable of initiating a signaling cascade in neurons. Therefore, N IL -16 may have dual f unctions in the nervous system, serving as a signaling molecule that is secreted after caspase-3 induction and as a cytosolic scaffolding protein that anchors ion channels in the membrane.
(both from Molecular Probes). Samples without the addition of each primary antibody were used as negative controls for the nonspecific binding and the cross-activation of fluoroprobes.
Protein preparations and Western blot anal ysis. For the characterization of N IL -16 protein in various brain regions, tissue lysates from P18 mice were prepared from eye, cerebellum, cortex, and hippocampus, respectively. Fresh frozen tissues were homogenized in cold tissue lysis buffer [containing (in mM) 50 Tris-HC l, pH 7.5, 250 NaC l, and 1 EDTA plus 0.1% N P-40 and 20% glycerol], using a Dounce homogenizer with a loose pestle. Lysates were cleared by centrif ugation in a 5415C microcentrif uge (Eppendorf, Hamburg, Germany) at 13,000 rpm for 15 min. Potein samples (100 g) were separated by SDS-PAGE on a 7.5% gel. For size comparison, 3 l of an extract prepared from N IL -16-transfected C OS-7 cells (see below) was included in the analysis. Proteins subsequently were electroblotted onto an Immobilon-P membrane (Millipore, Bedford, M A), and N IL -16 immunoreactivity was detected by Western analysis as described [Bonifacino et al. (1998) , chapter 6.2], with the anti-IL -16 antibody 14.1 (PharMingen) serving as the primary antibody. The ECL Western blotting analysis system (Amersham Pharmacia Biotech) was used for the visualization of immunoreactive protein bands.
For protein analysis in CGN undergoing apoptosis, CGN were prepared as described above and cultured for 8 d in medium containing 25 mM K ϩ . Apoptosis was induced by switching to a culture medium containing 5 mM K ϩ in the presence or absence of Z-VAD (see above). At various times after the medium switch, cells (two 60 mm dishes of CGN per time point) were detached by scraping and were lysed for 10 min on ice in 150 l of cell lysis buffer [containing (in mM) 50 H EPES, pH 7.5, 150 NaC l, and 1 EDTA plus 0.5% sodium deoxycholate supplemented with Complete protease inhibitor cocktail (Boehringer Mannheim, Indianapolis, I N)]. Lysates were cleared as described above. The 20 g lysate proteins were separated by SDS-PAGE on a 7.5% gel and subjected to Western analysis with the anti-IL -16 antibody, 14.1, as described above. In parallel, 20 g protein samples were separated by SDS-PAGE on a 4 -20% gradient gel and analyzed by Western blot, using a rabbit polyclonal anti-caspase-3 antibody (PharMingen, catalog number 67341A), which recognizes the inactive nonprocessed form of caspase-3 (p32) as well as the 17 kDa subunit of active caspase-3 (p17).
For the detection of Fos and Jun expression in CGN exposed to exogenous IL -16, the CGN culture medium was changed and replaced with a medium containing no IL -16 or 0.1 M recombinant mouse IL -16. C ells were lysed at various times after the medium change. The 50 g lysate proteins were separated by SDS-PAGE on an 8% gel. Fos was detected with the rabbit polyclonal antibody, Fos2.2 (Miao and Curran, 1994) (gift from Dr. Tom Curran, St. Jude Children's Research Hospital, Memphis, TN). Jun was detected with the rabbit polyclonal antibody anti-c-Jun /AP-1 (Ab-1; C albiochem). An N IH-3T3 cell extract (New England Biolabs, Beverly, M A) served as a control for Jun. The control for phosphorylated Jun was a UV-irradiated N IH-3T3 cell extract (New England Biolabs).
Yeast two-hybrid anal ysis. Yeast two-hybrid analysis (Fields and Song, 1989) was performed in the Saccharomyces cerevisiae strain, S260 (gift from Dr. Steve Dalton, University of Adelaide, South Australia, Australia), which contains a LacZ reporter gene integrated into its genome (Kurschner and Morgan, 1996) . A f usion of the LexA DNA binding domain with N IL -16 codons 1-525 was created in the vector Y.LexA (Kurschner and Morgan, 1996) (gift from Dr. Steve Dalton) and served as bait in the two-hybrid analysis. Fusions of the Herpes simple x virus protein V P16 transcriptional activation domain with the cytoplasmic domains of various NMDA receptor subunits and inward rectifier potassium channels (K ir) were created by RT-PCR as described previously (Kurschner et al., 1998) . cDNA sequences of voltage-gated potassium channels (Kv) as well as the ␣1 subunit of a mouse brain class C calcium channel (mbC ␣1) were amplified from mouse brain by RT-PCR, using primers designed from published DNA sequences (for the respective GenBank accession numbers, see Table 1 ). PCR products were inserted into the yeast expression vector pSD.10a (Dalton and Treisman, 1992) (gift from Dr. Steve Dalton) in frame with the V P16 transcriptional activator domain. The V P16 f usion constructs served as prey in the yeast two-hybrid analysis. T wo-hybrid analysis of pairs of cloned cDNAs was performed as described (Kurschner and Morgan, 1996) .
GST-pull-down assays. A cDNA encoding mbC ␣1 amino acids 1847-2139 was inserted into the vector pT7␤plink (Dalton and Treisman, 1992) (gift from Dr. Steve Dalton) for in vitro transcription /translation. In vitro transcription /translation constructs of N R2D amino acids 839 -1323 as well as f ull-length K ir4.1 (amino acids 1-379), K ir4.2 (amino acids 1-375) and a mutated K ir4.1, which contained a serine to glycine mutation at position 377 and a valine to alanine exchange at residue 379 (K ir4.1mutC), were described elsewhere (Kurschner et al., 1998) . Proteins were translated in vitro, using the TN TCoupled Reticulocyte Lysate System (Promega, Madison, W I). Reactions were done in the presence of [ 35 S]methionine (Amersham Pharmacia Biotech) in a 50 l volume, using 2 g of plasmid DNA as a template. N IL -16 codons 1-297 were cloned into the vector pGEX-4T-1 (Amersham Pharmacia Biotech) and expressed in Escherichia coli as a glutathione S-transferase (GST) f usion protein. "Empty" pGEX-4T-1 vector encoded the GST protein alone and was expressed as a control. GST and GST-N IL -16 were purified from bacterial cell lysates as described in Ausubel et al. [(1995) , section 20.2]. GST-pull-down assays were performed according to standard protocols described in Ausubel et al. [(1995) , section 20.2], using 23 l of in vitro-translated [ 35 S]methionine-labeled proteins and equal amounts (in 25 l) of GST or GST-N IL -16, respectively, bound to glutathioneSepharose 4B beads (Amersham Pharmacia Biotech). Precipitated protein complexes were separated by SDS-PAGE on a 12% polyacrylamide gel. The in vitro translation reactions (0.3 l) were loaded as input controls. The gel was dried and autoradiographed.
Caspase-3 cleavage assay. Full-length N IL -16 cDNA, as well as an EcoRV/EcoRI restriction fragment corresponding to codons 705-1322 of N IL -16 (codons 7-624 of splenocyte-derived pro-IL -16), was inserted into the vector pT7␤plink (Dalton and Treisman, 1992) for in vitro transcription. C apped in vitro transcripts were generated as described (Bonifacino et al., 1998) in the absence of radionucleotides. Of each transcript 0.4 g was used separately as a template in 20 l of in vitro translation reactions with the Rabbit Reticulocyte Lysate System (Promega, Madison, W I) in the presence of [
35 S]methionine (Amersham Pharmacia Biotech). Translation products were split into two 10 l aliquots each, and 15 l of caspase-3 cleavage buffer [containing (in mM) 20 H EPES, pH 7.4, 100 NaC l, 20 DTT, and 0.5% N P-40] was added to each aliquot. One aliquot per transcript received 0.5 l (100 ng) purified, active recombinant human caspase-3 (PharMingen). All four aliquots were incubated at 37°C for 2 hr. Subsequently, the translation and cleavage products were separated by SDS-PAGE on a 4 -20% gradient gel. Protein bands were visualized by autoradiography.
Transfection of COS-7 cells; preparation of COS-7 e xtracts and conditioned medium. Full-length N IL -16 cDNA as well as codons 705-1322 of N IL -16 (codons 7-624 of splenocyte-derived pro-IL -16) was cloned into the mammalian expression vector pcDNA3 (Invitrogen, C arlsbad, CA). C OS-7 cells were transiently transfected with one of these constructs or with pcDNA3 vector, respectively, using LipofectAMINE (Life Technologies). Transfected cells were maintained overnight in DM EM (Bio Whittaker, Walkersville, MD) supplemented with 2 mM glutamine (Life Technologies) and 20% fetal calf serum (Harlan, Indianapolis, I N). Subsequently, the cells were washed with serum-free medium and incubated with serum-free medium for 48 hr. Thereafter, the conditioned medium was removed and concentrated 100-fold by centrif ugation in C entricon-10 concentrators (Amicon, Beverly, M A). The transfected C OS-7 cells were lysed for 10 min on ice in 1 ml of cell lysis buffer, and the lysates were cleared as described above. Then 10 l of lysate and concentrated medium, respectively, were separated by SDS-PAGE on a 4 -20% gradient gel and subjected to Western blot analysis with the anti-IL -16 antibody 14.1, as described above.
Coimmunoprecipitation (Co-IP) assay. C OS-7 cells were transiently transfected as described above with f ull-length N IL -16 (in pcDNA3; Invitrogen) in the presence or absence of f ull-length N R2A (in pTracer-C M V; Invitrogen) (a gift from Dr. Jim Boulter, UCL A, L os Angeles, CA). C ells were lysed as described (Lin et al., 1998) in Co-I P buffer (50 mM Tris-HC l, pH 7.5, 150 mM NaC l, and 1% sodium deoxycholate supplemented with Complete protease inhibitor cocktail; Boehringer Mannheim). Immunoprecipitation was performed as described (Lin et al., 1998) , using 0.6 g of rabbit anti-N R2A antibodies (catalog number A-6473; Molecular Probes) and protein A-Sepharose CL -4B beads (Sigma). Precipitated proteins were analyzed for the presence of N IL -16 by Western analysis with the antibody 14.1 as described above. 
The C-terminal cytoplasmic domains of various NMDA receptor subunits (NR), inward rectifier potassium channels (K ir), voltage-gated potassium channels (Kv), or the ␣1 subunit of the voltage-sensitive class C calcium channel (mbC ␣1) were coexpressed with NIL-16 amino acids 1-525 (serving as bait) in yeast and assayed for interaction in the two-hybrid system. The ion channel constructs were cloned by RT-PCR with primers designed from published sequences (see GenBank accession numbers). The amino acid residues included in the ion channel constructs are indicated. The C -terminal amino acid sequences are shown for all constructs. ϩ, Blue yeast colony color in the yeast two-hybrid assay, indicating protein interaction with NIL-16; Ϫ, white yeast colony color after 6 hr observation time, indicating the lack of N IL -16 binding.
RESULTS

Molecular cloning of NIL-16
A cDNA library made by using RNA extracted from adult mouse cerebellum was screened for proteins that bind to an artificial PDZ domain target peptide with the C -terminal sequence V-S-D-L, as described previously (Kurschner et al., 1998) . One plasmid isolated in the screen contained a cDNA of 925 bp in length that encoded part of a novel protein. This cDNA served as a probe to isolate a f ull-length N IL -16 cDNA from a mouse cerebellum cDNA library. Several overlapping cDNAs were aligned (data not shown), revealing that the initial cDNA contained the first 297 codons of a protein of 1322 amino acids. BLAST searches indicated that the f ull-length protein contained four PDZ domains but no other known protein motifs ( Fig. 1 ). Amino acids 1-698 represented novel sequences, whereas amino acids 699 -1322 were 99.4% identical (four mismatches; data not shown) to the published sequence of splenocyte-derived mouse pro-IL -16 (Keane et al., 1998 ) (GenBank accession number AF006001; Fig. 1 ). Therefore, the protein was termed "NIL-16" for "Neuronal IL -16."
Tissue distribution of NIL-16
Northern blot analysis of mouse tissue was performed with a cDNA probe that corresponded to N IL -16 codons 1058 -1195, which are contained within the published pro-IL -16 sequence (Fig. 1 ). This analysis detected the previously described (Keane et al., 1998) pro-IL -16 mRNA doublet of 2.5 and 3.5 kb in spleen and thymus RNA (Fig. 2 A) . In addition, novel mRNA species of ϳ5 kb were detected in total brain and cerebellum RNA (Fig.  2 A) . The size correlated well with the size of the f ull-length NIL-16 cDNA that we had cloned, which was 4994 bp in length (data not shown). Northern analysis of cerebellum RNA samples obtained from mice of different ages demonstrated that NIL-16 transcript levels increased steadily during postnatal cerebellar development. E xpression was maximal at P12 and stayed constant thereafter (Fig. 2 B) .
In situ hybridization analysis of adult mouse brain, which used a cRNA probe that corresponded to NIL-16 codons 1058 -1195, revealed striking expression of NIL-16 in the cerebellum and in the hippocampus. In the latter structure, NIL-16 was expressed strongly in the dentate gyrus as well as in the CA3 and CA4 regions of the hippocampus (Fig. 2D) . Lower expression levels were found in CA1 (Fig. 2 D) . The identical expression pattern was detected with a cRNA probe corresponding to NIL-16 codons 1-130 (data not shown).
Western analysis of different brain regions that used a monoclonal antibody specific for IL-16 identified a protein of ϳ180 kDa in cerebellar and hippocampal extracts (Fig. 2C) . Lysates from COS-7 cells, transfected with full-length NIL-16 cDNA, contained an immunoreactive protein band of approximately the same size, suggesting that the cloned cDNA encoded the fulllength protein (Fig. 2C) .
NIL-16 is expressed in postmitotic neurons
In situ hybridization analysis revealed that NIL-16 expression in the cerebellum started at P3 in the differentiated granule cells of the internal granular layer (IGL), whereas it was virtually absent from the mitotic and premigratory granule cells of the external granular layer (EGL) (Fig. 3A,B) . In the more mature cerebellum at P21, high levels of NIL-16 transcript were detected in the granule cell layer (GCL), whereas lower levels were observed in the Purkinje cell layer (PCL) (Fig. 3B) . In the hippocampus, NIL-16 expression was detected first in the CA3 and CA4 regions at P1 and then in the suprapyramidal blade of the dentate gyrus at P3 (Fig. 3A) . Here, transcripts were restricted mainly to the most mature granule cells, which are located at the outer regions of the fascia (Fig. 3B) . At P21, most granule neurons of the dentate gyrus were NIL-16-positive, and NIL-16-negative cells were found mainly in the region adjacent to the hilus (Fig. 3B) , which contains undifferentiated and proliferating cells (for review, see Gaarskjaer, 1986; Stanfield and Cowan, 1988) . Thus, within both the cerebellum and the hippocampus, NIL-16 tran- (Cho et al., 1992) are boxed; amino acid numbers are indicated at left and right. The horizontal arrow marks the start of splenocyte-derived pro-IL -16 (Keane et al., 1998) . The vertical arrow indicates the site of proteolytic cleavage of pro-IL-16 by caspase-3 (Z hang et al., 1998).
scripts were found predominantly in regions containing the most mature cell populations.
NIL-16 interacts with ion channels
Many PDZ domain proteins f unction as cytoskeletal elements that anchor transmembrane proteins to specialized submembranous locations. The C -terminal consensus sequence x-S/T-x-V/I, which is contained in a large number of neuronal ion channels, identifies proteins as possible PDZ ligands (Songyang et al., 1997) . Therefore, we investigated the possibility that NIL-16 binds to glutamate receptor subunits, potassium channels, or the class C ␣1 subunit of a mouse brain calcium channel (mbC ␣1) in the yeast two-hybrid system (Table 1) . In this assay, NIL-16 selectively associated with NMDA receptor 2 subunits, Kir2.0 and K ir4.0 family members, Kv4 channels, and mbC ␣1. In contrast, no binding to NMDA receptor 1-3a, K ir1.1a, Kir6.2, or Kv1 family members was observed. All of the ion channels that interacted with NIL-16 possessed the C-terminal consensus sequence x-S-x-V/I/L.
To confirm that NIL-16 can interact physically with ion channels, we performed pull-down experiments with a glutathione S-transferase (GST)-fused NIL-16 fragment containing the first PDZ domain (amino acids 1-297) and a selection of in vitrotranslated [
35 S]methionine-labeled NIL-16 ligands. A mutated Kir4.1 construct, Kir4.1mutC, in which the C-terminal amino acid sequence S-N-V was changed to G-N-A (Kurschner et al., 1998) , was included in the analysis. GST-NIL-16, but not GST alone, precipitated the C-terminal fragment of NR2D as well as full-length Kir4.1 (Fig. 4) . Similarly, although small amounts of Kir4.2 and the mbC ␣1 fragment were pulled down by GST alone, this precipitation was enhanced significantly by GST-NIL-16, indicating an association of NIL-16 with Kir4.2 and mbC ␣1. In contrast, the C-terminal mutant Kir4.1mutC did not associate with NIL-16 in this assay, suggesting that the interaction of NIL-16 with ion channels is dependent on the presence of the C-terminal consensus motif found in all of the identified NIL-16 ligands.
To demonstrate that NIL-16 is able to associate with its ligands inside a cell, we performed coimmunoprecipitation studies on transfected COS-7 cells. Cells were transfected with NIL-16 or cotransfected with NIL-16 and NR2A. Immunoprecipitation was done on cell lysates by using anti-NR2A antibodies. Precipitates were assayed for the presence of NIL-16 by immunoblotting. Although comparable amounts of NIL-16 were found in the lysates from both single-and cotransfected cells (Fig. 5, left  panel ) , only trace amounts were detectable in immunoprecipitates from cells that had been transfected with NIL-16 alone (Fig.  5, lane 3) . This unspecific precipitation of NIL-16 was amplified greatly in preparations from cells that had been cotransfected with NR2A (Fig. 5, lane 4 ) , demonstrating that overexpressed NIL-16 bound to NR2A in transfected COS-7 cells. We were unable to find conditions under which we could coimmunoprecipitate the two proteins from synaptic membrane preparations or CGN cultures (data not shown). This may be attributable to a relatively low abundance of the proteins or to a poor sensitivity of our reagents.
The subcellular localization of NIL-16 overlaps with that of NR2C
The subcellular localization of NIL-16 in cultured CGN was compared with that of one of its ligands, NR2C, using immunofluorescence (Fig. 6 ). Immunoreactivity to NR2C was found in punctate clusters throughout the cell bodies and the neurites. NIL-16 immunoreactivity also was detected in clusters as well as larger patches in both the cell bodies and the neurites. It overlapped partially with the distribution of NR2C. This colocalization was concentrated particularly at neuritic branch points.
NIL-16 is a caspase-3 substrate
During the activation of CD4 ϩ T-cells, IL-16 release from its precursor correlated with caspase-3 activation (Wu et al., 1999) . Moreover, it was established recently that splenocyte-derived pro-IL-16 is an in vitro substrate for caspase-3 (Zhang et al., 1998) . To test if NIL-16 could be processed similarly by caspase-3, we incubated in vitro-translated radiolabeled fulllength NIL-16 and pro-IL-16 in the presence or absence of active recombinant caspase-3. After separation by SDS-PAGE and autoradiography, NIL-16 cleavage products were detected in caspase-3-treated samples (Fig. 7A) . Moreover, a protein fragment of ϳ18 kDa was found in both the N IL -16-and the pro-IL-16-containing samples. This indicated that, like pro-IL-16, NIL-16 was processed by caspase-3 to generate mature IL-16. The finding that the apparent sizes of the cleavage products was identical in caspase-3-treated samples of both N IL -16 and pro-IL-16 suggested that IL -16 was cleaved off the C termini of NIL-16 and pro-IL -16 at analogous sites.
COS-7 cells have an intrinsic caspase-3-like activity, and they have been shown to secrete mature IL -16 after transfection with pro-IL -16 (Z hang et al., 1998 ). Therefore, we tested whether the cleavage of N IL -16 by caspase-3 in transfected C OS-7 cells gave rise to a similarly secreted form of IL -16. C OS-7 cells transfected with N IL -16 and pro-IL -16 as well as conditioned medium were subjected to Western analysis by using a monoclonal antibody specific for the IL-16 epitope. Unprocessed NIL-16 and pro-IL-16, respectively, were found only in the corresponding cell lysates (Fig. 7B) . Processed, mature IL-16 was detected in the conditioned medium from both NIL-16-and pro-IL-16-transfected cells (Fig. 7B) , demonstrating that processing of NIL-16, like that of pro-IL-16, resulted in the release of a secreted cleavage product.
NIL-16 processing parallels caspase-3 activation in primary cerebellar granule cell cultures undergoing apoptosis
Postmitotic CGN can be cultured in vitro in the presence of 25 mM K ϩ (depolarizing conditions), but they undergo a cell death program with morphological features of apoptosis when they are maintained in nondepolarizing conditions (5 mM K ϩ ) (Yan et al., 1994). One feature of this paradigm of CGN apoptosis is the activation of caspase-3 (Armstrong et al., 1997; Ni et al., 1997; Marks et al., 1998) , which occurs via cleavage of the 32 kDa proenzyme into the 12 and 17 kDa subunits of the active enzyme (Fernandes-Alnemri et al., 1994; Nicholson et al., 1995; Tewari et al., 1995) . Therefore, we assayed the processing of NIL-16 in apoptotic CGN. CGN cultures were prepared from P7 mouse cerebellum and kept under depolarizing conditions for 8 d. Subsequently, the medium was switched to nondepolarizing conditions, and the cells were lysed for protein preparation at various time points (Fig. 8) . The lysates were examined by Western analysis for the presence of N IL -16 and caspase-3 proteins, respectively. The anti-IL -16 antibody 14.1 that was used in this assay recognizes the IL -16 epitope, which is cleaved off the C terminus of N IL -16 by caspase-3. The anti-caspase-3 antiserum recognizes both the inactive pro-form of caspase-3 (p32) and the p17 subunit of processed, active caspase-3. As shown in Figure  8 A, inactive pro-caspase-3 was present at all of the time points that were analyzed, whereas the p17 subunit of active caspase-3 was found only after the induction of apoptosis. During the time course that was examined, the levels of full-length NIL-16 was diminished progressively (Fig. 8 A) . In contrast, when the caspase-3 inhibitor Z-VAD was included in the culture medium, both caspase-3 activation and NIL-16 processing were reduced dramatically (Fig. 8 B) . This suggested that NIL-16 was processed by caspase-3 during apoptosis of CGN.
Cerebellar granule neurons induce c-fos in response to IL-16
Granule cells of the cerebellum are among the neurons that have been shown to express the IL-16 receptor CD4 (Omri et al., 1994) . Therefore, we investigated whether cultured CGN had the potential to respond to exogenous IL-16. To this end, the culture medium was replaced with medium containing no IL-16 or 0.1 M recombinant mouse IL-16, respectively, and CGN were incubated for various lengths of time (Fig. 9) . A CGN culture that had not been subjected to medium change served as a control (untreated). Low levels of Fos were detected in lysates from untreated cells. Medium change alone induced a slight increase in Fos protein, which was apparent between 30 min and 2 hr after a medium change. However, stimulation with IL-16 resulted in a dramatic upregulation of Fos expression, which peaked at 1 hr after medium change. This effect was transient, because Fos levels in CGN treated with IL-16 for 8 hr were similar to those found in untreated cells (Fig. 9) .
Induction of c-fos in cerebellar granule neurons involves tyrosine phosphorylation
To reveal the signaling pathways involved in mediating Fos upregulation, we performed IL-16 treatment of CGN in the presence and absence of various signaling pathway inhibitors (Fig.  10 ). Cells were pretreated with the inhibitors for 3 hr before IL-16 was added to a final concentration of 0.1 M. After 1 hr of continued incubation the Fos levels in cell lysates were determined by Western analysis. Although basal levels of Fos were low in the absence of IL-16 (Fig. 10, lane 1 
IL-16 treatment does not induce Jun phosphorylation in cerebellar granule neurons
Studies in activated macrophages showed that IL-16 induced rapid and transient phosphorylation of Jun in these cells, which peaked 15 min after the start of treatment (Krautwald, 1998) . Therefore, we investigated whether IL-16 had a similar effect on cultured CGN. CGN were treated with 0.1 M IL-16 for 15 and 30 min, respectively. A CGN culture that had not been exposed to IL-16 served as a control for Jun expression in CGN. Cell extracts were subjected to Western analysis with an anti-Jun antibody (Fig. 11 ). An NIH-3T3 cell extract was a control for Jun protein 35 S]methionine. The cDNA templates used in the in vitro translation reactions are indicated above the lanes. The respective codons included in the N R2D and mbC ␣1 constructs are shown in parentheses. K ir constructs encoded the full-length proteins. NIL -16 (amino acids 1-297) was expressed and purified from E. coli as a glutathione S-transferase (GST) f usion protein; unfused GST protein was expressed as a control. Lef t, Shown is 0.3 l of the in vitro translation reactions (input controls). Right, GST-pull-down assays were performed with in vitro-translated proteins, as indicated above the lanes, and equal amounts of GST (Ϫ) or GST-N IL -16 (ϩ), respectively, as bait. Precipitated proteins were analyzed by SDS-polyacrylamide electrophoresis and subsequent autoradiography. (lane 1), and a UV-irradiated National Institutes of Health-3T3 cell extract was a control for phosphorylated Jun (P-Jun, lane 2). Figure 11 shows that IL -16 treatment for 15 or 30 min did not lead to Jun phosphorylation in CGN. Similarly, longer IL-16 treatments for up to 8 hr did not affect the phosphorylation state of Jun (data not shown).
DISCUSSION
It has been recognized for some time that the immune system and the C NS share a variety of signaling molecules that regulate cellular f unction. For example, cytokines such as IL -1 and IL-2 and their receptors, which originally were described in the immune system, also are expressed by neurons in the brain (Cunningham et al., 1992; Yan et al., 1992; Farrar et al., 1987) . The identification of N IL -16 as a neuronal variant of the lymphokine IL-16 marks another molecular parallel between the immune and the nervous systems.
Mature IL -16 is the only known secreted member of the PDZ protein family. However, like in the case of IL -1, the mechanism of secretion remains elusive, because neither IL -1 nor IL-16 possesses a leader sequence that would target it for conventional release pathways. IL-16 exerts its function in the immune system via binding to its cell surface receptor, CD4, on T-lymphocytes, eosinophils, and monocytes (for review, see Center et al., 1996) . Although neuronal CD4 expression was reported previously (Funke et al., 1987; Omri et al., 1994) , its ligand IL-16 has not been described in the brain. Because the function of CD4-expressing immune cells is different from that of neurons and glia, CD4 receptor engagement by IL-16 is likely to have different functional consequences in the CNS. Notably, whereas IL-16 has been demonstrated to induce Jun phosphorylation in activated macrophages (Krautwald, 1998) , it did not do so in cultured CGN. Nonetheless, CGN responded to IL-16 by upregulating expression of the transcription factor Fos, indicating that an IL-16 signaling pathway exists in these cells. In activated macrophages, A, Apoptosis of CGN was induced by a medium switch to nondepolarizing conditions. C ell lysates were prepared at various times thereafter (indicated above the lanes) and subjected to Western analysis. The antibody used for the detection of N IL -16 recognized the IL -16 epitope, which is cleaved off the C terminus by caspase-3. The anti-caspase-3 antibody recognized both the inactive proenzyme (p32) and the p17 subunit of the active caspase. C aspase-3 activation was detected at all time points analyzed after the medium switch. In parallel, immunoreactivity against f ull-length N IL -16 was diminished progressively. B, The caspase inhibitor Z-VAD was included in the medium at the time of the switch to nondepolarizing conditions. Western analysis of cell lysates was performed as described in A. Under these conditions the caspase-3 activation and N IL -16 processing were greatly reduced. The positions of NIL-16, procaspase-3, and active caspase-3 (p17) in the gel are indicated on the left. p38 M APK becomes rapidly phosphorylated after IL -16 stimulation (Krautwald, 1998) . However, signaling via p38 M APK does not seem to be a major pathway in the upregulation of Fos in CGN, because the inhibitor SB202190 did not interfere significantly with Fos expression. In contrast, the IL -16-signaling pathway in CGN is likely to involve tyrosine phosphorylation, because the tyrosine kinase inhibitor herbimycin A completely abolished Fos upregulation. In T-lymphocytes the binding of IL -16 to CD4 results in the activation of the src family tyrosine kinase p56 lck (Ryan et al., 1995) , which is bound tightly to the cytoplasmic tail of CD4 (Rudd et al., 1988; Veillette et al., 1988) . Therefore, it is conceivable that, in CGN, the activation of a p56 lck -like kinase is part of the signaling pathway that leads to Fos upregulation. However, further experiments have to be performed to clarify this point.
In addition to the similarity in tissue distribution of IL-1 and IL-16 (both being expressed in the immune system as well as the CNS), another striking parallel between the two peptides involves their release from a precursor via proteolytical cleavage involving a caspase. In the case of IL-1␤, maturation is achieved by way of caspase-1 (Cerretti et al., 1992; Thornberry et al., 1992) , whereas IL-16 is released from its precursor by caspase-3 cleavage in both the immune (Zhang et al., 1998; Wu et al., 1999) and the nervous systems (this study). The involvement of caspase-3 during apoptosis was recognized initially in the immune system (FernandesAlnemri et al., 1994) . However, high expression levels of caspase-3 have been found during postnatal brain development (Ni et al., 1997) , indicating that this protease may play a role in developmental cell death in the brain. Studies of caspase-3-deficient mice, which display profound deficiencies in brain development and decreased apoptosis in the brain (Kuida et al., 1996) , support this notion. A low level of caspase-3 expression persists throughout adulthood (Ni et al., 1997) , suggesting that caspase-3 has additional functions after the naturally occurring cell death program is completed. Because the caspase-3 expression pattern in adult brain overlaps strikingly with that of NIL-16 in the hippocampus and the cerebellum (Ni et al., 1997) , we propose that, in the adult, caspase-3 functions in the processing of NIL-16 to mature secreted IL-16. It remains to be determined whether, after cleavage, the N-terminal portion of NIL-16 stays in the cytosol or whether it is subject to secretion or degradation. However, we conclude from the coimmunoprecipitation study with NR2A (see Fig. 5 ) as well as from Western analysis of lysates from transfected COS-7 cells (see Fig. 7B ) that at least a part of all cellular full-length NIL-16 molecules is localized within the cell.
In contrast to the findings with other cytokines and neurotrophins such as IL-10, IL-13, and ciliary neurotrophic factor, which are capable of delaying apoptosis of cultured CGN (de Luca et al., 1996) , IL-16 had no effect on the time course of apoptosis in CGN, as judged by Hoechst 33258 staining (data not shown). This was similar to the observations made in HIV-infected T-cells (Baier et al., 1995) and in activated macrophages (Krautwald, 1998) . Therefore, the processing of NIL-16 by caspase-3 in the adult brain may have functional consequences that are unrelated to the cell death program. Given the strikingly restricted expression pattern of NIL-16 in the regions of the brain that can undergo synaptic plasticity, such as long-term potentiation and long-term depression, it is reasonable to hypothesize that IL-16 may contribute to in these processes. This would be similar to the effects of IL-1␤, which inhibited synaptic strength and long-term potentiation in the hippocampus (Bellinger et al., 1993; Katsuki et al., 1990; Coogan and O'Connor, 1997) .
Although our data suggest that NIL-16 can be processed by caspase-3 to give rise to a secreted signaling molecule with autocrine effects on cerebellar granule neurons, our data also show that NIL-16 may function as a molecular anchor for transmembrane proteins. PDZ domains [also called "GLGF domains," for the relatively conserved tetrapeptide Gly-Leu-Gly-Phe contained in their primary sequence (Cho et al., 1992) ] have been described as protein interaction motifs that are found in an emerging class of structurally related proteins. These proteins for 15 and 30 min, respectively. C ell extracts were subjected to Western analysis with an antibody that recognizes both Jun and phosphorylated Jun (P-Jun). An NIH-3T3 cell extract was used as a control for Jun protein, and a UV-irradiated N IH-3T3 cell extract was used as a control for P-Jun. The positions of Jun and P-Jun in the gel are indicated on the left.
typically f unction as intracellular cytoskeletal elements that cluster their ligands at specific subcellular locations (for review, see Ponting et al., 1997; Sheng and Wyszynski, 1997) . This is achieved via an interaction between a PDZ domain and the C terminus of a respective ligand (Songyang et al., 1997) . Indeed, N IL-16 was found in clusters throughout the cytosol of cultured CGN. Moreover, N IL -16 was able to associate with a battery of ion channels that possess the C -terminal consensus sequence x-S-x-V/I/L. Among the N IL -16-interacting proteins was the ␣1 subunit of a mouse brain class C calcium channel (mbC ␣1) (Ma et al., 1992) . This constitutes the first report of an interaction between a class C calcium channel and a PDZ domain protein.
It is not surprising to observe that the tissue distribution and subcellular localization of N IL -16 overlap only partially with the NIL-16 binding proteins, because these ligands typically can associate with a variety of different PDZ domain proteins. For example, one prototype of the PDZ domain protein family, PSD-95/SAP90 (Cho et al., 1992; K istner et al., 1993) , binds several of the NIL -16 binding proteins, including NMDA receptor subunits (Kornau et al., 1995; Niethammer et al., 1996) and K ir channels (Cohen et al., 1996; Horio et al., 1997) . PSD-95/SAP90 is confined mainly to dendrites, but it is virtually absent from cell bodies (Cho et al., 1992; Kornau et al., 1995) . Consequently, its subcellular distribution overlaps only in dendrites with, for example, NMDA receptor subunits, which also are found in cell bodies. In contrast, N IL -16 partially colocalized with N R2C in both the dendrites and the cell bodies. Therefore, it is conceivable that interactions between different PDZ domain proteins with a given ion channel occur selectively at certain subcellular locations. Indeed, targeting of ion channels to a specific region in the cell membrane may be a unique property of an individual PDZ domain protein. Studies in mutant mice in which single PDZ domain proteins have been eliminated will be required to investigate this possibility.
Interestingly, all of the observed protein interactions involved the N-terminal neuron-specific portion of N IL -16, although we did not detect associations of ion channels with either of the two C-terminal PDZ domains (data not shown). In the case of the fourth PDZ domain, which constitutes the major part of mature IL-16, this is not surprising, because NMR structures of IL-16 revealed an unusual GLGF cleft with an occluded peptide binding site (Muhlhahn et al., 1998) . Therefore, this portion of NIL-16 is unlikely to serve as a cytosolic anchor for transmembrane proteins in a manner that involves the typical association with a C-terminal x-S/ T-x-V/I/L motif. However, it is not excluded that this domain engages in other types of intracellular protein interactions. This possibility, as well as the unveiling of ligands of the third PDZ domain in N IL -16, will be the focus of f uture studies.
In summary, we hypothesize that N IL -16 has dual f unctions in the CNS as a secreted signaling molecule and as a scaffolding protein. Moreover, it is conceivable that ligand-receptor interactions and intracellular signaling are coupled via N IL -16. Indeed, receptor occupation may regulate N IL -16 processing. Future experiments are aimed at addressing this question.
